目前,细胞和分子生物学技术在心血管系统疾病方面的研究进展有助于迎来核心脏病学的新时代———分子显像,虽然灌注显像将依然是一项用于确定可疑CAD诊断及评价预后的重要工具,但如今这种情况正在发生变化。我们再次处于一个重要的转折关头,必须考虑到现在用核心脏病学的成像技 Currently, advances in cellular and molecular biology techniques in cardiovascular disease help usher in a new era in nuclear cardiology-molecular imaging, although perfusion imaging will remain a useful tool in the identification of suspicious CAD diagnoses and An important tool to evaluate the prognosis, but this situation is changing. Once again, we are at an important turning point, and we must take into account the fact that now imaging with nuclear cardiology